Cargando…

Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis

IMPORTANCE: Cadherin‐11 (CDH11), a cell‐to‐cell adhesion molecule, is implicated in the fibrotic process of several organs. Biliary atresia (BA) is a common cholestatic liver disease featuring cholestasis and progressive liver fibrosis in children. Cholestatic liver fibrosis may progress to liver ci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bo, Tian, Xinbei, Wang, Weipeng, Zhu, Jing, Lu, Ying, Du, Jun, Xiao, Yongtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218970/ https://www.ncbi.nlm.nih.gov/pubmed/35774522 http://dx.doi.org/10.1002/ped4.12317

Ejemplares similares

Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19
por: Tian, Xinbei, et al.
Publicado: (2021)

Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling
por: Tian, Xinbei, et al.
Publicado: (2022)

Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride
por: Pedroza, Mesias, et al.
Publicado: (2019)

Beta-amyloid Deposition in Biliary Atresia Reduces Liver Regeneration by Inhibiting Energy Metabolism and Mammalian Target of Rapamycin Signaling
por: Tian, Xinbei, et al.
Publicado: (2022)

Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis
por: Wan, Xiaoyu, et al.
Publicado: (2020)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

Inositol hexaphosphate promotes intestinal adaptation in short bowel syndrome via an HDAC3-mediated epigenetic pathway
por: Wang, Weipeng, et al.
Publicado: (2023)

PHB2 interacts with LC3 and SQSTM1 is required for bile acids-induced mitophagy in cholestatic liver
por: Xiao, Yongtao, et al.
Publicado: (2018)

Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism
por: Šisl, Dino, et al.
Publicado: (2022)

Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
por: Li, Rina, et al.
Publicado: (2023)

Intestinal Reg4 deficiency confers susceptibility to high-fat diet-induced liver steatosis by increasing intestinal fat absorption in mice
por: Wang, Ying, et al.
Publicado: (2023)

Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury
por: Katsumata, Len William, et al.
Publicado: (2017)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)

Cadherin-11 expression is upregulated in invasive human breast cancer
por: Pohlodek, Kamil, et al.
Publicado: (2016)

Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
por: Svinka, Jasmin, et al.
Publicado: (2016)

ERRγ suppression by Sirt6 alleviates cholestatic liver injury and fibrosis
por: Hao, Lihua, et al.
Publicado: (2020)

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
por: Kimura, Masamichi, et al.
Publicado: (2022)

Farnesoid X receptor contributes to oleanolic acid‐induced cholestatic liver injury in mice
por: Feng, Hong, et al.
Publicado: (2022)

Guidelines for the Management of Cholestatic Liver Diseases (2021)
por: Lu, Lungen
Publicado: (2022)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)

The Role of Inflammation in Cholestatic Liver Injury
por: Chen, Jie, et al.
Publicado: (2023)

Bile acid-mediated signaling in cholestatic liver diseases
por: Zeng, Jing, et al.
Publicado: (2023)

Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis
por: Li, Sha, et al.
Publicado: (2021)

Induced Endothelial Cell-Integrated Liver Assembloids Promote Hepatic Maturation and Therapeutic Effect on Cholestatic Liver Fibrosis
por: Nam, Donggyu, et al.
Publicado: (2022)

Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells
por: Wang, Xingqi, et al.
Publicado: (2020)

Chronic Cholestatic Liver Injury Attributable to Vedolizumab
por: Stine, Jonathan G., et al.
Publicado: (2016)

Cellular crosstalk during cholestatic liver injury
por: Thomson, Joanne, et al.
Publicado: (2017)

Cholestatic liver diseases: An era of emerging therapies
por: Samant, Hrishikesh, et al.
Publicado: (2019)

The Role of Vitamin K in Cholestatic Liver Disease
por: Sultana, Halima, et al.
Publicado: (2021)

Fibrotic Events in the Progression of Cholestatic Liver Disease
por: Wu, Hanghang, et al.
Publicado: (2021)

Human Hepatocellular response in Cholestatic Liver Diseases
por: Ortiz, Kimberly, et al.
Publicado: (2023)

Evaluation and Management of Chronic Cholestatic Liver Diseases
por: Rini, Sandra Surya, et al.
Publicado: (2023)

Intestinal Microbiome‐Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice
por: Isaacs‐Ten, Anna, et al.
Publicado: (2020)

Rare variant contribution to cholestatic liver disease in a South Asian population in the United Kingdom
por: Zöllner, Julia, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptor Gamma Agonist Attenuates Liver Fibrosis by Several Fibrogenic Pathways in an Animal Model of Cholestatic Fibrosis
por: Alatas, Fatima Safira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dgto2henqr3ma14qhnlmmrvn6q